litigation

News

Jazz pays $145m to resolve Xyrem antitrust disputes

Jazz Pharma has offered to pay $145m to settle claims it paid to prevent generic versions of its narcolepsy drug Xyrem from reaching the US market.

News

Third time not so lucky in J&J's bid to end talc liability

Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming its talc-based products harmed consumers has failed.

News

US District Court for the Western District of Washington at Seattle

AbbVie sues Genmab, claiming trade secrets theft

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets.

News

Judge blocks mass firings of federal agency workers

A judge in California has said that the Trump administration's mass termination of probationary workers at federal agencies is likely to be unlawful.

News

When licensing deals go bad - Novo sues KBP Bio for $830m

Novo Nordisk lawsuit claims KBP concealed clinical data ahead of a $1.3bn licensing deal for blood pressure drug candidate ocedurenone.

News

Pfizer offers $60m to settle prescriber kickback claims

Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.

Jazz pays $145m to resolve Xyrem antitrust disputes

Third time not so lucky in J&J's bid to end talc liability

AbbVie sues Genmab, claiming trade secrets theft

Judge blocks mass firings of federal agency workers

When licensing deals go bad - Novo sues KBP Bio for $830m

Pfizer offers $60m to settle prescriber kickback claims

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

litigation

Editor's Picks